Phil Shin is a technology leader and liver cancer survivor who became involved with the American Liver Foundation after his diagnosis. Following a life-saving living donor transplant in 2019, he has remained cancer-free and now advocates for the liver community as an ALF board member and marathon participant.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities.
Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand.
You can read more about our editorial policy here.
